Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

Clinical trial NCT02593071 · COMPLETED

Trial details

NCT number: NCT02593071
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2015-10-01
Primary completion: 2016-11-01
Enrollment: 1330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.